WDNA Holdings — WisdomTree BioRevolution Fund
All 81 reported holdings of WisdomTree BioRevolution Fund (WDNA) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Twist Bioscience Corp. | 5.95% | $159.26K |
| Moderna, Inc. | 4.14% | $110.93K |
| Eli Lilly & Company | 4.08% | $109.15K |
| Johnson & Johnson | 2.97% | $79.49K |
| United Therapeutics Corp. | 2.45% | $65.56K |
| Natera, Inc. | 2.32% | $62.16K |
| Tempus Ai, Inc. | 2.28% | $61.12K |
| Immunome, Inc. | 2.26% | $60.39K |
| Structure Therapeutics, Inc. | 2.11% | $56.62K |
| Stoke Therapeutics, Inc. | 2.09% | $56.02K |
| Beam Therapeutics, Inc. | 2.09% | $55.87K |
| Corteva, Inc. | 1.99% | $53.27K |
| Krystal Biotech, Inc. | 1.96% | $52.41K |
| Darling Ingredients, Inc. | 1.94% | $51.83K |
| Ionis Pharmaceuticals, Inc. | 1.86% | $49.71K |
| Astrazeneca PLC | 1.83% | $48.92K |
| 10x Genomics, Inc. | 1.81% | $48.46K |
| Crispr Therapeutics AG | 1.77% | $47.34K |
| Roivant Sciences Ltd. | 1.73% | $46.36K |
| Absci Corp. | 1.71% | $45.65K |
| Revolution Medicines, Inc. | 1.69% | $45.13K |
| Agios Pharmaceuticals, Inc. | 1.57% | $42.08K |
| Amgen, Inc. | 1.54% | $41.28K |
| Bayer AG | 1.53% | $41.01K |
| Thermo Fisher Scientific, Inc. | 1.52% | $40.61K |
| Gilead Sciences, Inc. | 1.51% | $40.43K |
| Bunge Global SA | 1.51% | $40.34K |
| Arrowhead Pharmaceuticals, Inc. | 1.47% | $39.45K |
| Veracyte, Inc. | 1.46% | $39.11K |
| Biohaven Ltd. | 1.37% | $36.80K |
| Novonesis A/s | 1.37% | $36.76K |
| Pfizer, Inc. | 1.34% | $35.98K |
| Vertex Pharmaceuticals, Inc. | 1.34% | $35.76K |
| Novartis AG | 1.33% | $35.62K |
| Uniqure NV | 1.23% | $32.84K |
| Catalyst Pharmaceuticals, Inc. | 1.07% | $28.73K |
| Exelixis, Inc. | 1.04% | $27.97K |
| Cullinan Therapeutics, Inc. | 1.04% | $27.90K |
| Protagonist Therapeutics, Inc. | 1.03% | $27.46K |
| Dyne Therapeutics, Inc. | 1.00% | $26.76K |
| Celldex Therapeutics, Inc. | 0.96% | $25.82K |
| Editas Medicine, Inc. | 0.95% | $25.53K |
| Argenx SE | 0.94% | $25.05K |
| Viking Therapeutics, Inc. | 0.93% | $24.93K |
| Regenxbio, Inc. | 0.93% | $24.91K |
| Cg Oncology, Inc. | 0.90% | $24.16K |
| Biontech SE | 0.88% | $23.45K |
| Biogen, Inc. | 0.82% | $22.04K |
| Allogene Therapeutics, Inc. | 0.82% | $21.90K |
| Iovance Biotherapeutics, Inc. | 0.77% | $20.56K |
| Danaher Corp. | 0.75% | $20.00K |
| Repligen Corp. | 0.72% | $19.37K |
| Merck & Company, Inc. | 0.70% | $18.76K |
| Sana Biotechnology, Inc. | 0.67% | $17.99K |
| Verbio Vereinigte Bioenergie SE | 0.66% | $17.72K |
| Halozyme Therapeutics, Inc. | 0.65% | $17.38K |
| Ultragenyx Pharmaceutical, Inc. | 0.60% | $15.99K |
| Syensqo Sa/nv | 0.59% | $15.81K |
| Fmc Corp. | 0.58% | $15.61K |
| Insmed, Inc. | 0.58% | $15.57K |
| Green Plains, Inc. | 0.58% | $15.53K |
| Arcturus Therapeutics Holdings, Inc. | 0.55% | $14.68K |
| Illumina, Inc. | 0.54% | $14.42K |
| Regeneron Pharmaceuticals, Inc. | 0.54% | $14.34K |
| Intellia Therapeutics, Inc. | 0.53% | $14.23K |
| Nufarm Ltd. | 0.50% | $13.32K |
| Bio-Techne Corp. | 0.49% | $13.07K |
| Bridgebio Pharma, Inc. | 0.48% | $12.81K |
| Biomarin Pharmaceutical, Inc. | 0.44% | $11.67K |
| Genmab A/s | 0.42% | $11.21K |
| Oxford Nanopore Technologies PLC | 0.40% | $10.70K |
| Zoetis, Inc. | 0.36% | $9.70K |
| Genus PLC | 0.34% | $9.12K |
| Geron Corp. | 0.33% | $8.76K |
| Rocket Pharmaceuticals, Inc. | 0.30% | $7.90K |
| Tyson Foods, Inc. | 0.30% | $7.90K |
| Alnylam Pharmaceuticals, Inc. | 0.29% | $7.83K |
| Sarepta Therapeutics, Inc. | 0.28% | $7.53K |
| Pacific Biosciences Of California, Inc. | 0.26% | $7.09K |
| Qiagen NV | 0.25% | $6.73K |
| Dreyfus Trsy Oblig Cash M | 0.11% | $2.87K |
WDNA overview: performance, fees, allocation and SEC filings